<div id="readability-page-1"><p>Revvity Inc. (NYSE:RVTY - Get Free Report) has earned a consensus recommendation of &#34;Hold&#34; from the thirteen analysts that are  covering the company, MarketBeat reports. One investment analyst  has rated the stock with a sell recommendation, six have given a hold recommendation and six have assigned  a buy recommendation to  the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $113.9091.</p><p>A number of equities analysts have issued reports on RVTY shares. Barclays raised their price objective on shares of Revvity from $105.00 to $115.00 and gave the stock an &#34;overweight&#34; rating in a research report on Monday, December 15th. Weiss Ratings  reissued a &#34;sell (d)&#34; rating on shares of Revvity in a research note on Monday, December 29th. The Goldman Sachs Group initiated coverage on shares of Revvity in a report on Tuesday, December 9th. They issued a &#34;neutral&#34; rating and a $105.00 price target for the company. Bank of America downgraded shares of Revvity from a &#34;buy&#34; rating to a &#34;neutral&#34; rating and set a $110.00 price target for the company. in a research note on Monday, December 15th. Finally, Evercore ISI  reissued an &#34;outperform&#34; rating on shares of Revvity in a research report on Monday, January 5th.</p><p><b>Read Our Latest Research Report on Revvity</b></p><h2>Institutional Investors Weigh In On Revvity</h2><p>A number of hedge funds have recently added to or reduced their stakes in RVTY. CYBER HORNET ETFs LLC acquired a new position in shares of  Revvity during the second quarter worth approximately $32,000.  Cromwell Holdings LLC raised its holdings in  Revvity by 141.4% during the fourth quarter. Cromwell Holdings LLC now owns 338 shares of the company's stock worth $33,000 after buying an additional 198 shares during the last quarter.  MUFG Securities EMEA plc acquired a new position in  Revvity during the second quarter worth $34,000.  UMB Bank n.a. lifted its stake in shares of  Revvity by 138.8% in the second quarter. UMB Bank n.a. now owns 406 shares of the company's stock valued at $39,000 after buying an additional 236 shares in the last quarter.  Finally, CVA Family Office LLC grew its holdings in shares of  Revvity by 79.0% during the second quarter. CVA Family Office LLC now owns 410 shares of the company's stock valued at $40,000 after buying an additional 181 shares during the last quarter. Institutional investors and hedge funds own  86.65% of the company's stock. </p><h2>Revvity Stock Performance</h2><p>RVTY stock opened at $116.64 on Friday. The firm has a market cap of $13.22 billion, a PE ratio of 58.61, a price-to-earnings-growth ratio of 3.57 and a beta of 1.05. The company has a current ratio of 1.75, a quick ratio of 1.44 and a debt-to-equity ratio of 0.36. The stock has a 50-day moving average price of $102.18 and a 200-day moving average price of $95.02. Revvity has a 1-year low of $81.36 and a 1-year high of $128.29. </p><p>Revvity (NYSE:RVTY - Get Free Report) last released its earnings results on Monday, October 27th. The company reported $1.18 EPS for the quarter, topping the consensus estimate of $1.14 by $0.04. The business had revenue of $698.95 million during the quarter, compared to analysts' expectations of $699.75 million. Revvity had a return on equity of 7.52% and a net margin of 8.44%.The firm's revenue was up 2.2% on a year-over-year basis. During the same quarter last year, the firm posted $1.28 earnings per share. Revvity has set its FY 2025 guidance at 4.900-5.000 EPS.  As a group, equities research analysts expect that  Revvity will post 4.94 earnings per share for the current year. </p><p>Revvity declared that its board has authorized a share repurchase program on Monday, October 27th that permits the company to buyback $1.00 billion in  outstanding  shares. This buyback authorization permits the company to repurchase up to 8.7% of its shares through open market purchases. Shares buyback programs are generally an indication that the company's board believes its shares are undervalued. </p><h2>About Revvity</h2> (Get Free Report)<p>Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics. </p><p>Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.</p><h2>Recommended Stories</h2><ul><li>Five stocks we like better than Revvity</li><li>How a Family Trust May Be Able To Help Preserve Your Wealth</li><li>Do not delete, read immediately</li><li>The $100 Trillion AI Story No One Is Telling You</li><li>NEW LAW: Congress Approves Setup For Digital Dollar?</li><li>“Fed Proof” Your Bank Account with THESE 4 Simple Steps</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVJWVFk?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="600" height="385" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVJWVFk"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Revvity Right Now?</h2><p>Before you consider Revvity, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Revvity wasn't on the list.</p><p>While Revvity currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

RVTY

<p>Revvity Inc. (NYSE:RVTY) has received a consensus rating of "Hold" from thirteen analysts. The stock has one sell, six hold, and six buy recommendations. The average 12-month price target is $113.91. Barclays raised its price target to $115, while Bank of America downgraded it to $110. Revvity's stock opened at $116.64, with a market cap of $13.22 billion. The company reported $1.18 EPS for the last quarter, exceeding estimates, and announced a $1 billion share buyback program, indicating confidence in its stock value.</p>

Revvity Inc. (NYSE:RVTY) Receives Consensus Rating of "Hold" from Analysts